Literature DB >> 32128816

T-cells producing multiple combinations of IFNγ, TNF and IL10 are associated with mild forms of dengue infection.

Marcela Helena Gonçalves Pereira1, Maria Marta Figueiredo2, Camila Pereira Queiroz1, Télcia Vasconcelos Barros Magalhães3, Adriana Mafra4, Lilian Martins Oliveira Diniz5, Último Libânio da Costa6, Kenneth J Gollob7, Lis Ribeiro do Valle Antonelli2, Helton da Costa Santiago1,8.   

Abstract

Multifunctional interleukin 10 (IL10)+ Th1 cells have been implicated in favorable evolution of many infectious diseases, promoting an efficacious immune response while limiting immunopathology. Here, we investigated the presence of multifunctional CD4+ and CD8+ T-cells that expressed interferon gamma (IFNγ), IL10 and tumor necrosis factor (TNF), or its combinations during dengue infection. Peripheral blood mononuclear cells (PBMCs) from outpatients with dengue (mild dengue forms) and hospitalized patients (or patients with dengue with warning signs and severe dengue) were cultured in the presence of envelope (ENV) or NS3 peptide libraries of DENV during critical (hospitalization period) and convalescence phases. The production of IFNγ, IL10 and TNF by CD4+ and CD8+ T-cells was assessed by flow cytometry. Our data show that patients with mild dengue, when compared with patients with dengue with warning signs and severe dengue, presented higher frequencies of multifunctional T-cells like NS3-specific IFNγ/IL10-producing CD4+ T-cells in critical phase and NS3- and ENV-specific CD8+ T-cells producing IFNγ/IL10. In addition, NS3-specific CD8+ T-cells producing high levels of IFNγ/TNF and IFNγ/TNF/IL10 were also observed in the mild dengue group. We observed that multifunctional T-cells produced higher levels of cytokines as measured by intracellular content when compared with single producer T-cells. Importantly, multifunctional CD4+ and CD8+ T-cells producing IFNγ, TNF and IL10 simultaneously displayed positive correlation with platelet levels, suggesting a protective role of this population. The presence of IL10+ Th1 and IL10+ Tc1 multifunctional cells was associated with mild dengue presentation, suggesting that these cells play a role in clinical evolution of dengue infection.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  IL10+Tc1; IL10+Th1; dengue; immunoregulation; multifunctional T-cells

Mesh:

Substances:

Year:  2020        PMID: 32128816      PMCID: PMC7160666          DOI: 10.1111/imm.13185

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  64 in total

1.  Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity.

Authors:  S Green; D W Vaughn; S Kalayanarooj; S Nimmannitya; S Suntayakorn; A Nisalak; A L Rothman; F A Ennis
Journal:  J Med Virol       Date:  1999-11       Impact factor: 2.327

Review 2.  Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.

Authors:  Anuja Mathew; Elizabeth Townsley; Francis A Ennis
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

3.  Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever.

Authors:  Ana B Perez; Beatriz Sierra; Gissel Garcia; Eglis Aguirre; Nina Babel; Mayling Alvarez; Licel Sanchez; Luis Valdes; Hans D Volk; Maria G Guzman
Journal:  Hum Immunol       Date:  2010-08-21       Impact factor: 2.850

4.  Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma.

Authors:  Kien Duong Thi Hue; Trung Vu Tuan; Hanh Tien Nguyen Thi; Chau Tran Nguyen Bich; Huy Huynh Le Anh; Bridget A Wills; Cameron P Simmons
Journal:  J Virol Methods       Date:  2011-08-05       Impact factor: 2.014

5.  A detrimental role for invariant natural killer T cells in the pathogenesis of experimental dengue virus infection.

Authors:  Joelle Renneson; Rodrigo Guabiraba; Isabelle Maillet; Rafael E Marques; Stoyan Ivanov; Josette Fontaine; Christophe Paget; Valérie Quesniaux; Christelle Faveeuw; Bernhard Ryffel; Mauro M Teixeira; François Trottein
Journal:  Am J Pathol       Date:  2011-08-16       Impact factor: 4.307

6.  Antibody-dependent cellular cytotoxicity mediated by plasma obtained before secondary dengue virus infections: potential involvement in early control of viral replication.

Authors:  Kamolwish Laoprasopwattana; Daniel H Libraty; Timothy P Endy; Ananda Nisalak; Supamit Chunsuttiwat; Francis A Ennis; Alan L Rothman; Sharone Green
Journal:  J Infect Dis       Date:  2007-03-07       Impact factor: 5.226

7.  The human CD8+ T cell responses induced by a live attenuated tetravalent dengue vaccine are directed against highly conserved epitopes.

Authors:  Daniela Weiskopf; Michael A Angelo; Derek J Bangs; John Sidney; Sinu Paul; Bjoern Peters; Aruna D de Silva; Janet C Lindow; Sean A Diehl; Stephen Whitehead; Anna Durbin; Beth Kirkpatrick; Alessandro Sette
Journal:  J Virol       Date:  2014-10-15       Impact factor: 5.103

Review 8.  Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection.

Authors:  Maria G Guzman; Mayling Alvarez; Scott B Halstead
Journal:  Arch Virol       Date:  2013-03-08       Impact factor: 2.574

9.  IFNγ/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children.

Authors:  Prasanna Jagannathan; Ijeoma Eccles-James; Katherine Bowen; Felistas Nankya; Ann Auma; Samuel Wamala; Charles Ebusu; Mary K Muhindo; Emmanuel Arinaitwe; Jessica Briggs; Bryan Greenhouse; Jordan W Tappero; Moses R Kamya; Grant Dorsey; Margaret E Feeney
Journal:  PLoS Pathog       Date:  2014-01-09       Impact factor: 6.823

10.  Suppression of virus specific immune responses by IL-10 in acute dengue infection.

Authors:  Gathsaurie Neelika Malavige; Chandima Jeewandara; K M Luckmaal Alles; Maryam Salimi; Laksiri Gomes; Achala Kamaladasa; S D Jayaratne; Graham Stuart Ogg
Journal:  PLoS Negl Trop Dis       Date:  2013-09-05
View more
  8 in total

1.  Pregnant Women Infected with Zika Virus Show Higher Viral Load and Immunoregulatory Cytokines Profile with CXCL10 Increase.

Authors:  Elizabeth Camacho-Zavala; Clara Santacruz-Tinoco; Esteban Muñoz; Rommel Chacón-Salinas; Ma Isabel Salazar-Sanchez; Concepción Grajales; Joaquin González-Ibarra; Victor Hugo Borja-Aburto; Thomas Jaenisch; Cesar R Gonzalez-Bonilla
Journal:  Viruses       Date:  2021-01-08       Impact factor: 5.048

2.  A single-dose live attenuated chimeric vaccine candidate against Zika virus.

Authors:  Wei-Xin Chin; Regina Ching Hua Lee; Parveen Kaur; Tian Sheng Lew; Thinesshwary Yogarajah; Hao Yuin Kong; Zi-Yun Teo; Cyrill Kafi Salim; Rong-Rong Zhang; Xiao-Feng Li; Sylvie Alonso; Cheng-Feng Qin; Justin Jang Hann Chu
Journal:  NPJ Vaccines       Date:  2021-01-29       Impact factor: 7.344

Review 3.  Current Understanding of the Role of T Cells in Chikungunya, Dengue and Zika Infections.

Authors:  Maheshi Mapalagamage; Daniela Weiskopf; Alessandro Sette; Aruna Dharshan De Silva
Journal:  Viruses       Date:  2022-01-25       Impact factor: 5.048

4.  Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease.

Authors:  Vivian Vasconcelos Costa; Michelle A Sugimoto; Mauro Perretti; Mauro Martins Teixeira; Josy Hubner; Caio S Bonilha; Celso Martins Queiroz-Junior; Marcela Helena Gonçalves-Pereira; Jianmin Chen; Thomas Gobbetti; Gisele Olinto Libanio Rodrigues; Jordana L Bambirra; Ingredy B Passos; Carla Elizabeth Machado Lopes; Thaiane P Moreira; Kennedy Bonjour; Rossana C N Melo; Milton A P Oliveira; Marcus Vinicius M Andrade; Lirlândia Pires Sousa; Danielle Gloria Souza; Helton da Costa Santiago
Journal:  Elife       Date:  2022-03-16       Impact factor: 8.140

5.  Individuals with obesity who survive SARS-CoV-2 infection have preserved antigen-specific T cell frequencies.

Authors:  Neil E Wrigley Kelly; Grace Kenny; Féaron C Cassidy; Alejandro A Garcia-Leon; Conor De Barra; Patrick W G Mallon; Andrew E Hogan; Donal O'Shea
Journal:  Obesity (Silver Spring)       Date:  2022-09-01       Impact factor: 9.298

Review 6.  The impact of immuno-aging on SARS-CoV-2 vaccine development.

Authors:  Jennifer Connors; Matthew R Bell; Jennifer Marcy; Michele Kutzler; Elias K Haddad
Journal:  Geroscience       Date:  2021-02-11       Impact factor: 7.713

Review 7.  Immune Dysregulation in Autism Spectrum Disorder: What Do We Know about It?

Authors:  Maria de Los Angeles Robinson-Agramonte; Elena Noris García; Jarasca Fraga Guerra; Yamilé Vega Hurtado; Nicola Antonucci; Neomar Semprún-Hernández; Stephen Schultz; Dario Siniscalco
Journal:  Int J Mol Sci       Date:  2022-03-11       Impact factor: 5.923

Review 8.  Peculiarities of Zika Immunity and Vaccine Development: Lessons from Dengue and the Contribution from Controlled Human Infection Model.

Authors:  Helton C Santiago; Tertuliano A Pereira-Neto; Marcela H Gonçalves-Pereira; Ana C B Terzian; Anna P Durbin
Journal:  Pathogens       Date:  2022-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.